AssetMark Inc’s Audentes Therapeutics, Inc BOLD Stock Holding History

AssetMark Inc’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-35	Closed	-$2K	–	1605
2019 Q4	$2K	Hold	35	–	–	﹤0.01%	1282
2019 Q3	$1K	Buy	+35	New	+$1.2K	﹤0.01%	1298
2018 Q1	–	Sell	-21	Closed	-$1K	–	2191
2017 Q4	$1K	Buy	+21	New	+$577	﹤0.01%	1800

AssetMark Inc's BOLD Position: Q1 2020 in Review

AssetMark Inc sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 35 shares — an estimated $2K sold.

AssetMark Inc first reported a position in BOLD in Q4 2017 and held it in 3 quarters. The position peaked at $2K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

AssetMark Inc reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
AssetMark Inc sold 35 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $2K.
AssetMark Inc first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 3 quarters.
AssetMark Inc's Audentes Therapeutics, Inc position peaked at $2K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on AssetMark Inc's 13F filing for Q1 2020, filed 12 May 2020.